Pathomic immune biomarkers define recurrence risk in early-stage melanoma
Thazin Nwe Aung, Ajay Singh, Gerardo Espinoza, Chenxin Zhang et autres
3 citationsThe Oncologist
Basil A. Horst
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
160Publications signalées
2445Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and ManagementImmunotherapy and Immune ResponsesCAR-T cell therapy researchCell Image Analysis Techniques
Publications récentes
Sarcopenia in elderly patients hospitalized after intensive care unit admission
Cássio Vicente Pereira, Basil A. Horst, J.B. Carvalho, É. Suiter et autres
0 citationsClinical Nutrition ESPEN
The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative
Tess Aalto, Maria Abacan, Shirin Abadi, Farnoosh Abbas‐Aghababazadeh et autres
4 citationsCancer Cell
127 Digital pathology prognostic biomarkers- time for clinical application in melanoma
Yvonne Saenger, Chenxin Zhang, Gerardo Espinoza, Yadriel Bracero et autres
0 citationsRegular and Young Investigator Award Abstracts
1245 Spatial distribution and abundance of tumor cells, T cells and macrophages correlate with recurrence of stage II and III melanoma
Suryansh Shukla, Chenxin Zhang, Gerardo Espinoza, Samuel Wang et autres
0 citationsRegular and Young Investigator Award Abstracts
Correlation of eTILs with recurrence free survival (RFS) in stage IIB-IIIA melanoma and use as biomarker for stratification for clinical trials.
Thazin Nwe Aung, Chenxin Zhang, Gerardo Espinoza, Lawrence W. Leung et autres
1 citationJournal of Clinical Oncology
Abstract 1058: Immune biomarkers for recurrence in stage II and III melanoma to guide patient stratification
Gerardo Espinoza, Chenxin Zhang, Jee‐Young Moon, Divya Kenchappa et autres
0 citationsCancer Research
TERT promoter mutations in atypical melanocytic lesions: A series of seven cases with adverse melanoma-specific outcome
Jonathan Lee, Lisa Borretta, Basile Tessier‐Cloutier, Amy Lum et autres
2 citationsHuman Pathology
Utilization of p53 and p16 Immunohistochemistry in the Classification of Human Papillomavirus–Associated, p53 Wild-Type, and p53 Abnormal Oral Epithelial Dysplasia
Rachel Novack, Erin Chapman, Jiangyuan Gao, Basil A. Horst et autres
18 citationsModern Pathology
Extreme photometric and polarimetric variability of blazar S4 0954+65 at its maximum optical and $γ$-ray brightness levels
C. M. Raiteri, M. Villata, M. I. Carnerero, С. С. Савченко et autres
0 citationsarXiv (Cornell University)
B7‐H3 drives immunosuppression and Co‐targeting with CD47 is a new therapeutic strategy in β‐catenin activated melanomas
Min Hsu, Tiphaine Martin, Nikki S. Vyas, Garrett Desman et autres
6 citationsPigment Cell & Melanoma Research
Data from Quantitative Analysis of Immune Infiltrates in Primary Melanoma
Robyn D. Gartrell, Douglas K. Marks, Thomas D. Hart, Gen Li et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.